Table 1.

In silico analyses reported the characteristics of papers which compare the expression of the MMP9 and p65 proteins included in these analyses. The results were reported in Figure 3(a) through a heat map.

ID paper	Reference	Molecules analyzed		Proinflammatory action with respect to control	Anti-inflammatory action with respect to control	Markers	Pathology	Compound
		RNAs	Proteins
1	25	-	X	Y	Y	MMP9, TNF-α, IL-1β, other	Brain injury	Oxygen
2	26	X	X	Y	Y	MMP9, TNF-α, IL-1β, IL-6, p65	Colon cancer	miR-139
3	27	-	X	N	Y	MMP9, IL-6, other	Brest cancer	Ilamycin C
4	28	-	X	Y	Y	MMP9, IL-1β	Inflammatory mechanism	miR-100
5	29	X	-	N	Y	MMP9, IL-1β, IL-6	Inflammatory mechanism	NG-NAR
6	30	X	X	Y	N	MMP9, p65, other	Neck cancer	Oro-A
7	31	X	-	N	Y	p65	Inflammatory mechanism	Olive oil
8	32	X	X	Y	Y	MMP9, TNF-α, IL-6, p65, other	Inflammatory mechanism	FimA
9	33	X	X	Y	Y	MMP9, AKT, p65, other	Brain injury	Galangin
10	34	X	X	Y	Y	MMP9, TNF-α, IL-6, p65, other	Inflammatory mechanism	ANGPTL-8
11	35	X	X	Y	Y	MMP9, p65, other	Inflammatory mechanism	miR-145
12	36	X	X	Y	Y	MMP9, IL-6, p65, other	Neck cancer	miR-21
13	37	X	X	Y	Y	MMP9, IL-6, p65, other	Osteosarcoma	IL-6

X:done; -: not done; Y: yes; N: no.